CLOZARIL Trademark

Trademark Overview

On Wednesday, September 29, 1982, a trademark application was filed for CLOZARIL with the United States Patent and Trademark Office. The USPTO has given the CLOZARIL trademark a serial number of 73394129. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, April 4, 2024. This trademark is owned by Sandoz, Inc.. The CLOZARIL trademark is filed in the Pharmaceutical Products category with the following description:

a Neuroleptic Indicated for the Management of Manifestations of Acute and Chronic Psychotic Disorders

General Information

Serial Number73394129
Word MarkCLOZARIL
Filing DateWednesday, September 29, 1982
Status800 - REGISTERED AND RENEWED
Status DateThursday, April 4, 2024
Registration Number1265560
Registration DateTuesday, January 31, 1984
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 8, 1983

Trademark Statements

Goods and Servicesa Neuroleptic Indicated for the Management of Manifestations of Acute and Chronic Psychotic Disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code6 - Active
Class Status DateTuesday, November 8, 1983
Primary Code005
First Use Anywhere DateThursday, August 26, 1982
First Use In Commerce DateThursday, August 26, 1982

Trademark Owner History

Party NameNOVARTIS AG
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameSandoz, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEast Hanover, NJ 07936
Party NameSandoz, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEast Hanover, NJ 07936
Party NameSandoz, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEast Hanover, NJ 07936

Trademark Events

Event DateEvent Description
Thursday, April 4, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, April 4, 2024REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Thursday, April 4, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 4, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 16, 2023TEAS SECTION 8 & 9 RECEIVED
Tuesday, January 31, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, December 14, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, December 14, 2013REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Saturday, December 14, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, December 6, 2013REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Saturday, December 14, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 6, 2013TEAS SECTION 8 & 9 RECEIVED
Tuesday, September 29, 2009REVIEW OF CORRESPONDENCE COMPLETE
Sunday, June 21, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 9, 2008CASE FILE IN TICRS
Sunday, December 19, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 6, 2004PAPER RECEIVED
Thursday, March 4, 2004REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, March 4, 2004REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, January 14, 2004REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Wednesday, January 14, 2004TEAS SECTION 8 & 9 RECEIVED
Wednesday, May 30, 1990REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 25, 1990REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, November 8, 1983PUBLISHED FOR OPPOSITION
Tuesday, January 31, 1984REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 1983PUBLISHED FOR OPPOSITION
Wednesday, September 21, 1983NOTICE OF PUBLICATION
Monday, August 22, 1983APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 24, 1983ASSIGNED TO EXAMINER

Related Keywords

clozaril chronic psychotic disorders acute manifestations indicated management neuroleptic